Lidocaine Hydrochloride Injection, Solution
Product Images NDC 51662-1454

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lidocaine Hydrochloride (NDC 51662-1454). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rfid Label (51662 1454 1 Rfid Label)

Rfid Label (51662 1454 1 Rfid Label)
DataMatrix barcode label with GS1 Application Identifiers including GTIN and batch/lot and expiration information. Text includes 'SEE MANUFACTURE'S INSERT' and distribution by HF Acquisitions Co., LLC Mukilteo, WA 98275. No medication brand, strength, or dosage form information is visible on this section of the label.*
FDA Label Image

Structure (51662 1454 1 Structure)

Structure (51662 1454 1 Structure)
Chemical structure of lidocaine hydrochloride showing the aromatic ring with two methyl groups and the side chain containing an amide and diethylamino groups, along with hydrochloride and hydrate components.*
FDA Label Image

Carton Label (51662 1454 1 Carton Label)

Carton Label (51662 1454 1 Carton Label)
Packaging label for Lidocaine HCl Injection USP, 2% strength (100 mg/5 mL, equivalent to 20 mg/mL), in a 5 mL single-dose syringe. The label includes usage instructions, manufacturer Hospira Inc., and highlights that the product is preservative free and intended for intravenous use for ventricular arrhythmias.*
FDA Label Image

Table 1 (51662 1454 1 Table 1)

Table 1 (51662 1454 1 Table 1)
A data table showing concentration, volume, and pH for Lidocaine Hydrochloride injection solution. It lists 5 mL volumes containing either 100 mg or 50 mg total Lidocaine HCl, at concentrations of 20 mg/mL and 10 mg/mL respectively, with pH ranges of 5.0 to 7.0 for intravenous direct injection and single-dose use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.